From November 17 to 28, 2024, nonprofit Orbis International is delivering training for eye care professionals in Bangladesh ...

Emmecell announced positive Phase 1 extension study results for EO2002, a nonsurgical cell therapy for corneal edema. The ...

Imagine a day when blurry vision becomes a barrier to your daily activities, and a world where glasses seem like the only ...

Livionex, recently announced a successful end-of-Phase 2 meeting with the FDA, supporting the advancement of C-KAD, a 2.6% EDTA ophthalmic solution, to a Phase 3 clinical study. In an interview with ...

The Valeda ® Light Delivery System (LumiThera, Inc.) is the first ever FDA-authorized treatment for vision loss in dry AMD, the manufacturer reported. The technology was evaluated in the LIGHTSITE III ...

Surya Eye Hospital unveils Western India's first Oculus Myopia Master for early detection, hosts free myopia screening camp from Nov 14-20: Our Bureau, Mumbai Friday, November 15, ...

Presbyopia is an age-related refractive condition marked by a gradual decline in near vision, typically emerging between ages ...

Diabetic retinopathy is a leading cause of vision loss among adults and often goes unnoticed until it reaches advanced stages ...

Optometry Unit, of Yenepoya School of Allied health sciences in collaboration with NSS Unit 4 organized an eye screening camp ...

As Air Quality Worsens, Global Scientist Urges Haryana to Lead with Mandatory Health Education for Children ...

The tech features a 2mm incision that allows for rapid correction of refractive errors with reduced risks and faster recovery ...

Detailed price information for Tarsus Pharmaceuticals Inc (TARS-Q) from The Globe and Mail including charting and trades.